ISOPX
Price
$18.61
Change
+$0.25 (+1.36%)
Updated
Sep 4 closing price
Net Assets
180.04M
VEXRX
Price
$112.44
Change
+$0.76 (+0.68%)
Updated
Sep 5 closing price
Net Assets
20.46B
Interact to see
Advertisement

ISOPX vs VEXRX

Header iconISOPX vs VEXRX Comparison
Open Charts ISOPX vs VEXRXBanner chart's image
Voya SmallCap Opportunities Port A
Price$18.61
Change+$0.25 (+1.36%)
VolumeN/A
Net Assets180.04M
Vanguard Explorer Adm
Price$112.44
Change+$0.76 (+0.68%)
VolumeN/A
Net Assets20.46B
ISOPX vs VEXRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ISOPX vs. VEXRX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ISOPX is a Hold and VEXRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 20.5B vs. ISOPX (180M). ISOPX pays higher dividends than VEXRX: ISOPX (2.09) vs VEXRX (0.50). ISOPX was incepted earlier than VEXRX: ISOPX (17 years) vs VEXRX (24 years). ISOPX (1.56) is less costly to investors than VEXRX (0.33). ISOPX is a more actively managed with annual turnover of: 115.00 vs. VEXRX (35.00). ISOPX has a lower initial minimum investment than VEXRX: ISOPX (0) vs VEXRX (50000). ISOPX annual gain was more profitable for investors over the last year : 8.61 vs. VEXRX (2.61). VEXRX return over 5 years is better than : 12.06 vs. ISOPX (0.45).
ISOPXVEXRXISOPX / VEXRX
Total Expense Ratio1.430.33433%
Annual Report Gross Expense Ratio1.560.33473%
Fund Existence17 years24 years-
Gain YTD3.9965.23276%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets180M20.5B1%
Annual Yield % from dividends2.090.50419%
Returns for 1 year8.612.61330%
Returns for 3 years46.3822.01211%
Returns for 5 years0.4512.064%
Returns for 10 years-27.7231.16-89%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FRBRX151.063.08
+2.08%
Franklin Biotechnology Discovery R6
AIEVX24.640.16
+0.65%
Invesco EQV International Equity R5
TPLIX14.660.08
+0.55%
Timothy Plan Large/Mid Cap Growth I
PBCJX50.39-0.42
-0.83%
Principal Blue Chip J
RYCYX149.86-1.54
-1.02%
Rydex Dow 2x Strategy C